CB-839 + Capecitabine in Solid Tumors and Fluoropyrimidine Resistant PIK3CA Mutant Colorectal Cancer
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
M.D. Anderson Cancer Center
NantBioScience, Inc.
Eisai Inc.
Roswell Park Cancer Institute
SillaJen, Inc.
UNC Lineberger Comprehensive Cancer Center
Isofol Medical AB
Stanford University
City of Hope Medical Center
Generic Devices Consulting, Inc.
MediGene
Stanford University
Massachusetts General Hospital
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Amgen